Physiopathology of osteoarthritis. From normal cartilage to osteoarthritic cartilage: susceptibility factors and inflammatory mechanisms;Physiopathologie de l'arthrose. Du cartilage normal au cartilage arthrosique : facteurs de prédisposition et mécanismes inflammatoires

Revue de Medecine Interne

Volumn 28, Issue 8, 2007, Pages 531-536

  Laadhar, L ^a   Zitouni, M ^a   Kalle Sellami, M ^a   Mahjoub, M ^a   Sellami, S ^a   Makni, S ^a  

^a LA RABTA HOSPITAL   (Tunisia)

Author keywords

Chondrocyte; Cytokines; Inflammation; Osteoarthritis

Indexed keywords

CYTOKINE; GROWTH FACTOR; INTERLEUKIN 10; INTERLEUKIN 1BETA; INTERLEUKIN 4; METALLOPROTEINASE; SOMATOMEDIN; TRANSFORMING GROWTH FACTOR;

AGING; CARTILAGE CELL; CARTILAGE DEGENERATION; CYTOKINE RELEASE; DISEASE PREDISPOSITION; HEREDITY; HUMAN; INFLAMMATION; OSTEOARTHRITIS; PATHOGENESIS; PATHOPHYSIOLOGY; PREVALENCE; RISK FACTOR; SHORT SURVEY; SYSTEMATIC REVIEW; WEIGHT BEARING; ARTICULAR CARTILAGE; REVIEW;

CARTILAGE, ARTICULAR; HUMANS; INFLAMMATION; OSTEOARTHRITIS; RISK FACTORS;

EID: 34447580047     PISSN: 02488663     EISSN: 17683122     Source Type: Journal    
DOI: 10.1016/j.revmed.2007.01.012     Document Type: Short Survey

References (53)

1. Petersson I.F., and Jacobsson L.T. Osteoarthritis of the peripheral joints. Best Pract. Res. Clin. Rheumatol. 16 (2002) 741-760
2. Hunter D.J., and Felson D.T. Osteoarthritis. BMJ 332 (2006) 639-642
3. Brandt K.D., Radin E.L., Dieppe P.A., and Van De Putte L. Yet more evidence that osteoarthritis is not a cartilage disease. Ann. Rheum. Dis. 65 (2006) 1261-1264
4. Aigner T., and Stove J. Collagens-major component of the physiological cartilage matrix, major target of cartilage degeneration, major tool in cartilage repair. Adv. Drug Deliv. Rev. 55 (2003) 1569-1593
5. Setton L.A., Elliott D.M., and Mow V.C. Altered mechanics of cartilage with osteoarthritis: human osteoarthritis and an experimental model of joint degeneration. Osteoarthritis Cartilage 7 (1999) 2-14
6. Kouri J.B., and Lavalle C. Do chondrocytes undergo activation or transdifferentiation during the pathogenesis of osteoarthritis? A review of the ultrastructural and immunochemical evidence. Histol. Histopathol. 21 (2006) 793-802
7. Aigner T., and Dudhia J. Phenotypic modulation of chondrocytes as a potential therapeutic target in osteoarthritis: a hypothesis. Ann. Rheum. Dis. 56 (1997) 287-291
8. Hamerman D. The biology of osteoarthritis. N. Engl. J. Med. 320 (1989) 1322-1330
9. Loeser R.F., and Shakoor N. Aging or osteoarthritis: which is the problem?. Rheum. Dis. Clin. North Am. 29 (2003) 653-673
10. Verzijl N., DeGroot J., Thorper S.R., Bank R.A., Shaw J.N., Lyons T.J., et al. Effect of collagen turnover on the accumulation of Advenced Glycation End products. J. Biol. Chem. 275 (2000) 39027-39031
11. Looser R.F., Yammani R.R., Carlson C.S., Chen H., Cole A., Im H.J., et al. Articular chondrocytes express the receptor for Advenced Glycation End products. Arhtritis Rheum 52 (2005) 2376-2385
12. Corvol M. Le chondrocyte: du vieillissement cellulaire au chondrocyte arthrosique. Rev. Rhum. 67 (2000) 673-676
13. Aigner T., Rose J., Martin J., and Buckwalter J. Aging theories of primary osteoarthritis: from epidemiology to molecular biology. Rejuvenation Res. 7 (2004) 134-145
14. Hannan M.T., Anderson J.J., Zangh Y., Levy D., and Felson D.T.L. Bone mineral density and knee osteoarthritis in elderly men and women: the Framingham study. Arthritis Rheum. 36 (1993) 1671-1680
15. Lee D.A., Noguchi T., Frean S.P., Lees P., and Bader D.L. The influence of mechanical loading on isolated chondrocytes seeded in agarose constructs. Biorheology 37 (2000) 149-161
16. Piscoya J.L., Fermor B., Kraus V.B., Stabler T.V., and Guilak F. The influence of mechanical compression on the induction of osteoarthritis-related biomarkers in articular cartilage explants. Osteoarthritis Cartilage 13 (2005) 1092-1099
17. Salter D.M., Millward-Sadler S.J., Nuki G., and Wright M.O. Integrin-interleukin-4 mechanotransduction pathways in human chondrocytes. Clin. Orthop. Relat. Res. 391 Suppl (2001) 49-60
18. Ala-Kokko L., Baldwin C.T., Moskowitz R.W., and Prockop D.J. Single base mutation in the type II procollagen gene (Col2A1) as a cause of primary osteoarthritis associated with a mild chondrodysplasia. Proc. Natl. Acad. Sci. USA 87 (1990) 6565-6568
19. MacGregor A.J., Antoniades L., Matson M., and Spector T.D. The genetic contribution to radiographic hip osteoarthritis: a population-based twin study. Arthritis Rheum. 41 (1998) S358
20. Spector T.D., Cicuttini F., Baker J., Loughlin J., and Hart D. Genetic influences on osteoarthritis in women: a twin study. BMJ 312 (1996) 940-943
21. Sambrook P.N., MacGregor A.J., and Spector T.D. Genetic influences on cervical and lumbar disc degeneration: a magnetic resonance imaging study in twins. Arthritis Rheum. 42 (1999) 366-372
22. Spector M.D., and MacGregor A.J. Risk factors for osteoarthritis: genetics. Osteoarthritis Cartilage 12 Suppl A (2004) S39-S44
23. Radin E.L., Paul I.L., and Rose R.M. Mechanical factors in osteoarthritis. Lancet 1 (1972) 519-522
24. Radin E.L. Who gets osteoarthritis and why?. J. Rheum. 31 (2004) 10-15
25. Aigner T., Kurz B., Fukui N., and Sandell L. Roles of chondrocytes in the pathogenesis of osteoarthritis. Curr. Opin. Rheumatol. 14 (2002) 578-584
26. Henrotin Y., and Reginster J.Y. Anabolic events in osteoarthritis. Osteoarthritis Cartilage 7 (1999) 310-312
27. Van Beuningen H.M., Van der Kraan P.M., Arntz O.J., and Van den Berg W.B. Transforming growth factor beta 1 stimulates articular chondrocyte proteoglycan synthesis and induces osteophyte formation in the murine knee joint. Lab. Invest. 71 (1994) 279-290
28. Shuler F.D., Georescu H.I., Niyibizi C., Studer R.K., Mi Z., Johnstone B., et al. Increased matrix synthesis following adenoviral transfer of a transforming growth factor beta 1 gene into articular chondrocytes. J. Orthop. Res. 18 (2000) 585-592
29. Bakker A.C., Van De Loo F.A., Van Beuningen H.M., Sime P., Van Lent P.L., Van der Kraan P.M., et al. Overexpression of active TGF beta-1 in the murine knee joint: evidence for synovial-layer dependent chondro-osteophyte formation. Osteoarthritis Cartilage 9 (2001) 128-136
30. Shlaak J.F., Meyer zum Buschenfelde K.H., and Marker-Hermann E. Different cytokine profiles in the synovial fluid of patients with osteoarthritis, rheumatoid arthritis and seronegative spondylarthropathies. Clin. Exp. Rheumatol. 14 (1996) 155-162
31. Enomoto-Iwamoto M., Iwamoto M., Mukudai Y., Kawakami Y., Nohno T., Higuchi Y., et al. Bone morphogenetic protein signalling is required for maintenance of differentiated phenotype, control of proliferation and hypertrophy in chondrocytes. J. Cell Biol. 140 (1998) 409-418
32. Martel-Pelletier J., Di Battista J., and Lajeunesse D. Biochemical factors in joint articular tissue degradation osteoarthritis. In: Reginster J.Y., Pelletier J.P., Pelletier J.M., and Henrotin Y. (Eds). Osteoarthritis clinical and experimental aspects (1999), Springer, Heidelberg 156-187 (éd)
33. Westacott C.I., Webb G.R., Warnock M.G., Sims J.V., and Elson C.J. Alteration of cartilage metabolism by cells from osteoarthritic bone. Arthritis Rheum. 40 (1997) 1282-1291
34. Kevorkian L., Young D.A., Darrah C., Donell S.T., Shepstone L., Porter S., et al. Expression profiling of metalloproteinases and their inhibitors in cartilage. Arthritis Rheum. 50 (2004) 131-141
35. Murphy G., and Lee M.H. What are the roles of metalloproteinases in cartilage and bone damage?. Ann. Rheum. Dis. 64 (2005) 44-47
36. Patwari P., Gao G., Lee J.H., Grodzinski A.J., and Sandy J.D. Analysis of ADAMTS4 and MT4-MMP indicates that both are involved in agrecanolysis in interleukine-1 treated bovine cartilage. Osteoarthritis Cartilage 13 (2005) 269-277
37. Blanco Garcia F.J. Catabolic events in osteoarthritic cartilage. Osteoarthritis Cartilage 7 (1999) 308-309
38. Mitchell P.G., Magna H.A., Reevs L.M., Lopresti-Morrow L.L., Yocum S.A., Rosner P.J., et al. Cloning expression and type II collagenolytic activity of matrix-metalloproteinase 13 from human osteoarthritic cartilage. J. Clin. Invest. 97 (1996) 761-768
39. Chevalier X. Upregulation of enzymatic activity by interleukin-1 in osteoarthritis. Biomed. Pharmacother. 51 (1997) 58-62
40. Goggs R., Carter S.D., Tanzil G.S., Shakibaei M., and Mobasheri A. Apoptosis and the loss of chondrocyte survival signals contribute to articular cartilage degradation in osteoarthritis. Vet. J. 166 (2003) 140-158
41. Pelletier J.P., Martel-Pelletier J., and Abramson S.B. Osteoarthritis, an inflammatory disease: potential implication for the selection of new therapeutic targets. Arthritis Rheum. 44 (2001) 1237-1247
42. Amin A., Dave M., Attur M., and Abramson S.B. Cox-2, NO and cartilage damage and repair. Curr. Rheumatol. Rep. 2 (2000) 447-453
43. Pelletier J.P., Mineau F., Ranger P., Tardif G., and Martel-Pelletier J. The increased synthesis of inducible nitric oxide inhibits IL1Ra synthesis by human articular chondrocytes: possible role in osteoarthritic cartilage degradation. Osteoarthritis Cartilage 4 (1996) 77-84
44. Berenbaum F. Anatomopathologie et pathogénie de l'arthrose. Rev. Rhum. 67 (2000) 119-125
45. Goldring M.B. The role of cytokines as inflammatory mediators in osteoarthritis: lessons from animal models. Conn Tiss Res 40 (1999) 1-11
46. Goldring M.B. Osteoarthritis and cartilage: the role of cytokines in this disorder. Curr. Rheumatol. Rep. 2 (2000) 459-465
47. Berenbaum F. Cytokines pro-inflammatoires, prostaglandines et chondrocyte : mécanisme d'activation intracellulaire. Rev. Rheum. 67 (2000) 677-680
48. Martel-Pelletier J., Alaaeddine N., and Pelletier J.P. Cytokines and their role in the pathophysiology of osteoarthritis. Front. Biosci. 15 (1999) D694-D703
49. Van den Berg W. Phsiopathologie de l'arthrose. Rev. Rheum. 67 (2000) 671-672
50. Taskiran D., Stefanovic-Racic M., Georgscu H., and Evans C. Nitric oxide mediates suppression of cartilage proteoglycan synthesis by interleukin-1. Biochem. Biophys. Res. Commun. 200 (1994) 142-148
51. Lotz M. The role of nitric oxide in articular cartilage damage. Rheum. Dis. Clin. North Am. 25 (1999) 269-282
52. Del Carlo M., and Loeser R.F. Nitric oxide-mediated chondrocyte cell death requires the generation of additional reactive oxygen species. Arthritis Rheum. 46 (2002) 394-403
53. Aigner T., Hemmel M., Neureiter D., Gebhard P.M., Zeiler G., Kirchner T., et al. Apoptotic cell death is not a wide-spread phenomenon in normal aging and osteoarthritic human articular knee cartilage: a study of proliferation, programmed cell death and viability of chondrocytes in normal and osteoarthritic human knee cartilage. Arthritis Rheum. 44 (2001) 1304-1312